Plain-English reading on the vagus nerve, its science and how to look after it
How It Works

The Role of the Trigeminal and Vagus Nerves in Neural Function

A flat folk-art illustration of a branching cranial nerve filled with a garden of bellflowers, asters and slender grasses.


The trigeminal nerve (cranial nerve V) and the vagus nerve (cranial nerve X) are usually discussed separately — one handles facial sensation, the other regulates organs. But they share brainstem circuitry in ways that produce some of the most clinically significant reflexes in medicine, and recent neuromodulation devices deliberately exploit these connections to treat conditions from epilepsy to migraine. This article focuses exclusively on where these two nerves interact.

The Brainstem Connection

The trigeminal and vagus nerves converge in the lower brainstem, where their nuclei are physically adjacent and connected by interneurons.

Trigeminal sensory afferents — carrying touch, pain, and temperature from the face — terminate in the spinal trigeminal nucleus, which extends from the pons down into the upper cervical spinal cord. The vagus nerve’s motor output to the heart originates primarily from the dorsal motor nucleus of the vagus and the nucleus ambiguus, both located in the medulla.

Short interneuron pathways in the reticular formation connect the spinal trigeminal nucleus to these vagal motor nuclei. This wiring means that strong trigeminal sensory input can trigger a rapid vagal motor response — specifically, bradycardia (slowed heart rate) and hypotension (lowered blood pressure). This connection is the anatomical basis for a family of reflexes that share the same fundamental arc: trigeminal afferent in, vagal efferent out.

The Trigeminocardiac Reflex

The trigeminocardiac reflex (TCR) is the umbrella term for any reflex where stimulation of a trigeminal nerve branch produces a vagal cardiac response — typically a sudden drop in heart rate, sometimes accompanied by hypotension, apnoea, or gastric hypermotility.

The reflex was first described in the context of eye surgery (the oculocardiac reflex, reported by Aschner in 1908) but is now recognised across all three trigeminal divisions. Different stimulation sites produce variants with the same underlying mechanism:

The Oculocardiac Reflex

Pressure on the eyeball or traction on the extraocular muscles activates the ophthalmic division (V1) of the trigeminal nerve. The afferent signal reaches the spinal trigeminal nucleus, crosses via interneurons to the dorsal vagal nucleus, and fires a vagal efferent response that slows the heart — sometimes dramatically. This reflex remains a significant concern during strabismus surgery, retinal detachment repair, and orbital procedures. Incidence rates in paediatric strabismus surgery range from 14% to 90% depending on the definition used and the surgical technique.

The Diving Reflex

When cold water contacts the forehead and periorbital skin, the ophthalmic branch of the trigeminal nerve detects the temperature drop and triggers a vagal response: heart rate slows by 10–25%, peripheral blood vessels constrict, and the spleen contracts to release stored red blood cells. This is the mammalian diving reflex — an oxygen-conservation response shared across aquatic and terrestrial mammals.

The full reflex requires two simultaneous inputs: cold facial contact (trigeminal) and breath-holding (which removes the respiratory modulation of vagal tone). Cold water on the hands or body alone does not trigger the same cardiac response. The face-specific nature of the reflex confirms its trigeminal origin.

Clinically, the diving reflex is used therapeutically as a vagal manoeuvre to terminate supraventricular tachycardia (SVT). Applying an ice-cold wet cloth to the forehead and cheeks for 15–30 seconds can produce enough vagal output to break a re-entrant tachycardia circuit. It is particularly useful in paediatric SVT, where the Valsalva manoeuvre is difficult to perform reliably.

Dental and Maxillofacial Triggers

The maxillary (V2) and mandibular (V3) branches can trigger the TCR during dental procedures, maxillofacial surgery, and nasal procedures. A 2024 prospective study of 188 patients undergoing dental procedures under sedation (published in BMC Oral Health) found that 41% experienced transient bradycardia, with 17% dropping below 60 bpm. The largest single drop recorded was 30 bpm, reaching a nadir of 41 bpm. Risk factors included gag reflex (odds ratio 5.6) and trait anxiety (odds ratio 2.5).

A 2025 case series in Frontiers in Physiology (Yamashita et al., Kagoshima University) used real-time HRV monitoring during dental treatment in three patients with a history of vasovagal episodes. They found that high-frequency HRV (a direct marker of vagal output) rose sharply before symptoms appeared, suggesting the trigeminal-vagal pathway activated before the patients felt unwell. In one case, pausing treatment whenever HF-HRV spiked prevented further vasovagal episodes over six months of follow-up.

Your local vagus nerve experts

Find a vagus nerve practitioner near you

Our directory lists 2,685 practitioners across the US, from polyvagal-informed therapists to HRV biofeedback clinics.

Or browse by approach

The directory covers the United States for now. Listings come from practitioners’ own websites and are not endorsements or medical advice. Browse the full directory.

Therapeutic Crossover: Stimulating One Nerve to Treat the Other’s Territory

The shared brainstem circuitry between the trigeminal and vagus nerves has created an unexpected therapeutic opportunity: stimulating the trigeminal nerve to produce effects normally associated with vagal activation.

Monarch eTNS for Epilepsy

NeuroSigma’s Monarch eTNS (external trigeminal nerve stimulation) system delivers low-level electrical stimulation to the supraorbital and supratrochlear branches of the trigeminal nerve — the V1 division — via adhesive electrodes on the forehead. The FDA granted it Breakthrough Device Designation for drug-resistant epilepsy (DRE).

In a randomised controlled trial of 40 adults with DRE published in Brain Stimulation, the eTNS group achieved a 50% responder rate at 12 months compared to 0% in the control group (P<.001), with a median seizure reduction of 43.5% versus 0% (P=.001). No significant adverse events were reported.

The mechanism is thought to involve trigeminal afferents projecting to the nucleus tractus solitarius (NTS) — the same brainstem nucleus that receives vagal afferents. From the NTS, signals propagate to the locus coeruleus (norepinephrine) and raphe nuclei (serotonin), modulating cortical excitability through the same neuromodulatory pathways engaged by implanted vagus nerve stimulation. In effect, eTNS accesses vagal brainstem circuitry through the trigeminal nerve's front door.

Cefaly for Migraine

The Cefaly device delivers transcutaneous electrical stimulation to the supraorbital nerve (V1) for migraine prevention. It is FDA-cleared and has demonstrated a reduction in monthly migraine days in multiple trials. While migraine involves the trigeminal system directly (the trigeminovascular pathway is central to migraine pathophysiology), the device’s effects on autonomic symptoms — nausea reduction, heart rate changes during attacks — suggest vagal co-activation through shared brainstem pathways.

Auricular Vagus Nerve Stimulation and Trigeminal Overlap

The ear is an unusual anatomical meeting point. The cymba conchae is innervated by the auricular branch of the vagus nerve (ABVN), while the tragus and external ear canal receive dual innervation from both the ABVN and the auriculotemporal branch of the trigeminal nerve (V3). This means that transcutaneous auricular devices stimulate both systems simultaneously, and isolating their individual contributions in clinical trials remains an active research challenge.

Clinical Significance

Understanding the trigeminal-vagal interaction matters in three practical contexts:

First, surgical safety. Any procedure involving the face, eyes, nose, teeth, or jaw carries a risk of triggering the TCR. Anaesthesiologists monitor for it and may pre-treat with atropine in high-risk cases. The 2025 Frontiers in Physiology case series suggests real-time HRV monitoring could provide early warning.

Second, acute cardiac management. The diving reflex and other trigeminal-vagal manoeuvres are first-line treatments for SVT. Knowing that the mechanism is trigeminal-to-vagal — and that it requires specific conditions (cold plus apnoea for the diving reflex, or sustained pressure for the oculocardiac reflex) — helps clinicians perform these manoeuvres correctly.

Third, neuromodulation. The shared brainstem architecture means the trigeminal nerve can serve as a non-invasive entry point to vagal circuits. This is driving development of external devices for epilepsy, migraine, depression, and potentially other conditions currently treated with implanted VNS.

The trigeminal-vagal connection is one of the most clinically relevant nerve interactions in the body. My Vagus Nerve & Me explores these pathways and what they mean for your health. Get the eBook here.

This article is for general information and is not medical advice. Talk to a qualified clinician before changing anything about your health or treatment. Read our medical disclaimer. Spotted an error? Let us know.